{"id":"https://openalex.org/W2182002115","doi":null,"title":"Effect of additives and solvents on inhibition of crystallization in transdermal patches containing repaglinide","display_name":"Effect of additives and solvents on inhibition of crystallization in transdermal patches containing repaglinide","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2182002115","mag":"2182002115"},"language":"en","primary_location":{"id":"mag:2182002115","doi":null,"is_oa":false,"landing_page_url":"http://www.ijpsr.info/docs/IJPSR14-05-02-010.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2182002115"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084557576","display_name":"Balaji Gummidi","orcid":"https://orcid.org/0000-0002-1444-3262","observed_orcids":["https://orcid.org/0000-0002-1444-3262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balaji Gummidi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1444-3262","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009991085","display_name":"Sudha Thamrapalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sudha Thamrapalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8788999915122986,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.8788999915122986,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.04500000178813934,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.04390000179409981,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/repaglinide","display_name":"repaglinide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.9710000157356262},{"id":"https://openalex.org/keywords/crystallization-inhibition","display_name":"crystallization suppression","score":0.8849999904632568},{"id":"https://openalex.org/keywords/crystal-growth","display_name":"crystal growth","score":0.6000000238418579},{"id":"https://openalex.org/keywords/additives","display_name":"additives","score":0.4560000002384186},{"id":"https://openalex.org/keywords/solvents","display_name":"solvents","score":0.9610000252723694},{"id":"https://openalex.org/keywords/plasticizers","display_name":"plasticizers","score":0.9369999766349792},{"id":"https://openalex.org/keywords/hydroxypropyl-methylcellulose","display_name":"hydroxypropyl methylcellulose","score":0.722000002861023},{"id":"https://openalex.org/keywords/hpc","display_name":"HPC","score":0.9950000047683716},{"id":"https://openalex.org/keywords/polyvinylpyrrolidone","display_name":"polyvinylpyrrolidone","score":0.996999979019165},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.843999981880188},{"id":"https://openalex.org/keywords/patch-formulation","display_name":"patch formulation","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2781281211","wikidata":"https://www.wikidata.org/wiki/Q2195995","display_name":"Repaglinide","level":4,"score":0.9562797546386719},{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.6672990322113037},{"id":"https://openalex.org/C205679159","wikidata":"https://www.wikidata.org/wiki/Q3375179","display_name":"Transdermal","level":2,"score":0.6606243252754211},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6093325614929199},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.5834884643554688},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5171113014221191},{"id":"https://openalex.org/C2775842315","wikidata":"https://www.wikidata.org/wiki/Q1145270","display_name":"Transdermal patch","level":3,"score":0.4364651143550873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.428706556558609},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.38670510053634644},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3647755980491638},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35364267230033875},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.19185706973075867},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14520218968391418},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.12284570932388306},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.10474589467048645}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2182002115","doi":null,"is_oa":false,"landing_page_url":"http://www.ijpsr.info/docs/IJPSR14-05-02-010.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W1907838421"],"related_works":["https://openalex.org/W2085920889","https://openalex.org/W2952429530","https://openalex.org/W4281652889","https://openalex.org/W2782558020","https://openalex.org/W2784069500","https://openalex.org/W3182596765","https://openalex.org/W2744261276","https://openalex.org/W7167571016","https://openalex.org/W2887147803"],"abstract_inverted_index":{"Repaglinide":[0,30,90],"is":[1,18,31,91,119],"used":[2],"as":[3,157,171],"antidiabetic":[4],"drug":[5],"it":[6,45],"has":[7,55,205],"half-":[8],"life":[9],"of":[10,29,50,89,109,125,142],"1":[11],"hour":[12],"and":[13,167,169,174,187,195],"bioavailability":[14],"in":[15,71,99,116],"the":[16,63,76,82,123,127,140,191,197,203],"body":[17],"56%":[19],"due":[20],"to":[21,56,61,69,80,105,179,189],"first":[22],"pass":[23],"metabolism.":[24],"The":[25,111],"total":[26],"daily":[27,39],"dose":[28],"16":[32],"mg":[33,36],"(e.g.,":[34],"4":[35],"four":[37],"times":[38],"depending":[40],"on":[41,144,193],"meal":[42],"patterns),":[43],"hence":[44],"required":[46],"frequent":[47],"dosing.":[48],"Because":[49],"its":[51,131],"low":[52],"halflife":[53],"repaglinide":[54],"be":[57],"administered":[58],"more":[59],"frequently":[60],"maintain":[62],"plasma":[64],"levels.":[65],"This":[66,133],"may":[67,78],"lead":[68],"reduction":[70],"patient":[72,77],"compliance":[73],"or":[74,129],"sometimes":[75],"fail":[79],"take":[81],"drug.":[83],"Therefore":[84],"a":[85,94],"modified":[86],"dosage":[87,96],"form":[88],"preferred":[92],"over":[93],"conventional":[95],"form.":[97],"Hence":[98],"our":[100],"present":[101],"work":[102,134],"we":[103],"planned":[104],"formulate":[106],"Transdermal":[107],"Patches":[108],"Repaglinide.":[110],"most":[112,198],"commonly":[113],"encountered":[114],"problem":[115],"transdermal":[117],"patches":[118,194],"crystal":[120,145],"growth":[121,146],"during":[122,130],"process":[124],"drying":[126],"patch":[128],"storage.":[132],"was":[135],"aimed":[136],"at":[137],"finding":[138],"out":[139],"effects":[141],"additives":[143],"inhibition.":[147],"Various":[148],"trails":[149,159],"were":[150,181],"conducted":[151],"by":[152,160,183],"using":[153,165,184],"different":[154],"formulations":[155,177],"such":[156],"placebo":[158],"following":[161],"single":[162],"blinded":[163],"tecnique":[164],"HPMC":[166],"HPC,":[168],"povidone":[170],"polymers,various":[172],"solvents":[173,186],"plasticizers.":[175],"Seventeen":[176],"(F-1":[178],"F-17)":[180],"prepared":[182],"differnts":[185],"polymers":[188],"observe":[190],"crystallization":[192,204],"finally":[196],"prefered":[199],"formulation":[200],"which":[201],"inhibits":[202],"been":[206],"selected.":[207]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
